Free Trial

IQ-AI (IQAI) Competitors

IQ-AI logo
GBX 0.84 +0.01 (+1.33%)
As of 04:13 AM Eastern

IQAI vs. FDBK, TRLS, DVRG, SENS, EMIS, CRW, INS, KOO, RENX, and COG

Should you be buying IQ-AI stock or one of its competitors? The main competitors of IQ-AI include Feedback (FDBK), Trellus Health (TRLS), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), Renalytix (RENX), and Cambridge Cognition (COG). These companies are all part of the "health information services" industry.

IQ-AI vs.

Feedback (LON:FDBK) and IQ-AI (LON:IQAI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, community ranking, valuation, analyst recommendations, media sentiment, institutional ownership, earnings, dividends and profitability.

In the previous week, IQ-AI had 1 more articles in the media than Feedback. MarketBeat recorded 1 mentions for IQ-AI and 0 mentions for Feedback. IQ-AI's average media sentiment score of 0.58 beat Feedback's score of 0.00 indicating that IQ-AI is being referred to more favorably in the news media.

Company Overall Sentiment
Feedback Neutral
IQ-AI Positive

IQ-AI has lower revenue, but higher earnings than Feedback.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Feedback£3.88M1.53-£10.84M-£24.74-0.55
IQ-AI£538.19K3.44N/AN/AN/A

Feedback has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500. Comparatively, IQ-AI has a beta of 2.25, indicating that its stock price is 125% more volatile than the S&P 500.

IQ-AI has a net margin of -77.52% compared to Feedback's net margin of -279.16%. Feedback's return on equity of -39.71% beat IQ-AI's return on equity.

Company Net Margins Return on Equity Return on Assets
Feedback-279.16% -39.71% -22.99%
IQ-AI -77.52%-140.75%-22.03%

53.2% of Feedback shares are held by institutional investors. 10.8% of Feedback shares are held by company insiders. Comparatively, 66.0% of IQ-AI shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Feedback received 159 more outperform votes than IQ-AI when rated by MarketBeat users. Likewise, 67.07% of users gave Feedback an outperform vote while only 66.67% of users gave IQ-AI an outperform vote.

CompanyUnderperformOutperform
FeedbackOutperform Votes
165
67.07%
Underperform Votes
81
32.93%
IQ-AIOutperform Votes
6
66.67%
Underperform Votes
3
33.33%

Summary

IQ-AI beats Feedback on 7 of the 13 factors compared between the two stocks.

Get IQ-AI News Delivered to You Automatically

Sign up to receive the latest news and ratings for IQAI and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IQAI vs. The Competition

MetricIQ-AIHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£1.85M£212.61M£5.33B£2.66B
Dividend Yield17.30%6.68%5.21%5.05%
P/E Ratio-13.67320.3826.71129.21
Price / Sales3.44433.24386.12221,406.01
Price / Cash10.2547.1438.2528.02
Price / BookN/A5.376.773.79
Net IncomeN/A-£15.55M£3.23B£5.88B
7 Day Performance0.36%1.11%1.80%0.63%
1 Month Performance1.95%8.16%11.10%22.11%
1 Year Performance-40.29%6.88%17.11%120.87%

IQ-AI Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IQAI
IQ-AI
N/AGBX 0.84
+1.3%
N/A-39.3%£1.85M£538,190.00-13.676News Coverage
Gap Up
FDBK
Feedback
N/AGBX 13.55
-1.5%
N/A-80.6%£5.94M£3.88M-0.5524
TRLS
Trellus Health
N/AGBX 1.71
-7.6%
N/A+24.6%£3.31M£65,831.01-0.5031Gap Up
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583,000.00£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560News Coverage
CRW
Craneware
2.5875 of 5 stars
GBX 2,210
+7.8%
GBX 2,800
+26.7%
-2.7%£949.56M£230.77M81.65734High Trading Volume
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500
KOO
Kooth
N/AGBX 134
+0.4%
GBX 456.67
+240.8%
-48.0%£49.18M£50.72M12.59478
RENX
Renalytix
N/AGBX 8.50
+3.0%
N/A-62.8%£35.24M£9.22M-0.40102
COG
Cambridge Cognition
N/AGBX 39
+5.4%
N/A-14.2%£16.33M£15.64M-10.3680Gap Up

Related Companies and Tools


This page (LON:IQAI) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners